Wang T, Zhai Y, Xue H, Zhou W, Ding Y, Nie H
Biomolecules. 2023; 13(4).
PMID: 37189326
PMC: 10135759.
DOI: 10.3390/biom13040578.
Kelaidonis K, Ligielli I, Letsios S, Vidali V, Mavromoustakos T, Vassilaki N
Int J Mol Sci. 2023; 24(9).
PMID: 37176159
PMC: 10179460.
DOI: 10.3390/ijms24098454.
Razi O, Teixeira A, Tartibian B, Zamani N, Knechtle B
Mol Cell Biochem. 2022; 478(7):1533-1559.
PMID: 36411399
PMC: 9684932.
DOI: 10.1007/s11010-022-04610-1.
Deben C, Le Compte M, Siozopoulou V, Lambrechts H, Hermans C, Lau H
Cancers (Basel). 2022; 14(17).
PMID: 36077610
PMC: 9454734.
DOI: 10.3390/cancers14174074.
Ghosh A, Ghosh B, Parihar N, Ilaweibaphyrnai M, Panda S, Alexander A
Food Biosci. 2022; 50:101977.
PMID: 36059903
PMC: 9423882.
DOI: 10.1016/j.fbio.2022.101977.
Actions of Novel Angiotensin Receptor Blocking Drugs, Bisartans, Relevant for COVID-19 Therapy: Biased Agonism at Angiotensin Receptors and the Beneficial Effects of Neprilysin in the Renin Angiotensin System.
Moore G, Ridgway H, Kelaidonis K, Chasapis C, Ligielli I, Mavromoustakos T
Molecules. 2022; 27(15).
PMID: 35956801
PMC: 9369639.
DOI: 10.3390/molecules27154854.
Diminazene Aceturate Reduces Angiotensin II Constriction and Interacts with the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2.
Matsoukas J, Kate Gadanec L, Zulli A, Apostolopoulos V, Kelaidonis K, Ligielli I
Biomedicines. 2022; 10(7).
PMID: 35885036
PMC: 9312513.
DOI: 10.3390/biomedicines10071731.
Discovery of a new generation of angiotensin receptor blocking drugs: Receptor mechanisms and in silico binding to enzymes relevant to SARS-CoV-2.
Ridgway H, Moore G, Mavromoustakos T, Tsiodras S, Ligielli I, Kelaidonis K
Comput Struct Biotechnol J. 2022; 20:2091-2111.
PMID: 35432786
PMC: 8994259.
DOI: 10.1016/j.csbj.2022.04.010.
discovery of non-psychoactive scaffolds in Cannabis halting SARS-CoV-2 host entry and replication machinery.
Khattab A, Teleb M
Future Virol. 2022; 0(0).
PMID: 35399958
PMC: 8982993.
DOI: 10.2217/fvl-2021-0309.
A Novel Soluble ACE2 Protein Provides Lung and Kidney Protection in Mice Susceptible to Lethal SARS-CoV-2 Infection.
Hassler L, Wysocki J, Gelarden I, Sharma I, Tomatsidou A, Ye M
J Am Soc Nephrol. 2022; 33(7):1293-1307.
PMID: 35236774
PMC: 9257820.
DOI: 10.1681/ASN.2021091209.
Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease.
Sabater Molina M, Nicolas Rocamora E, Bendicho A, Garcia Vazquez E, Zorio E, Dominguez Rodriguez F
PLoS One. 2022; 17(2):e0263140.
PMID: 35120165
PMC: 8815985.
DOI: 10.1371/journal.pone.0263140.
study of potential anti-SARS cell entry phytoligands from : a promising avenue for prophylaxis.
Khattab A, Teleb M, Kamel M
Future Virol. 2021; 0(0).
PMID: 34745316
PMC: 8559586.
DOI: 10.2217/fvl-2021-0031.
COVID-19 and dys-regulation of pulmonary endothelium: implications for vascular remodeling.
Jadaun P, Chatterjee S
Cytokine Growth Factor Rev. 2021; 63:69-77.
PMID: 34728151
PMC: 9611904.
DOI: 10.1016/j.cytogfr.2021.10.003.
Circulating furin, IL-6, and presepsin levels and disease severity in SARS-CoV-2-infected patients.
Kocyigit A, Sogut O, Durmus E, Kanimdan E, Guler E, Kaplan O
Sci Prog. 2021; 104(2_suppl):368504211026119.
PMID: 34187224
PMC: 10305811.
DOI: 10.1177/00368504211026119.
Association of hypercoagulation with severe acute respiratory syndrome coronavirus 2 infection.
Nuthalapati P, Ghanta M, Natesh N, L V K S B
Blood Res. 2021; 56(2):61-64.
PMID: 34083499
PMC: 8246040.
DOI: 10.5045/br.2021.2021011.
MSC-derived exosomes carrying a cocktail of exogenous interfering RNAs an unprecedented therapy in era of COVID-19 outbreak.
Jamalkhah M, Asaadi Y, Azangou-Khyavy M, Khanali J, Soleimani M, Kiani J
J Transl Med. 2021; 19(1):164.
PMID: 33888147
PMC: 8061879.
DOI: 10.1186/s12967-021-02840-3.
Epigenetic Lens to Visualize the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Infection in COVID-19 Pandemic.
Saksena N, Bonam S, Miranda-Saksena M
Front Genet. 2021; 12:581726.
PMID: 33828579
PMC: 8019793.
DOI: 10.3389/fgene.2021.581726.
Combination of Angiotensin (1-7) Agonists and Convalescent Plasma as a New Strategy to Overcome Angiotensin Converting Enzyme 2 (ACE2) Inhibition for the Treatment of COVID-19.
Issa H, Eid A, Berry B, Takhviji V, Khosravi A, Mantash S
Front Med (Lausanne). 2021; 8:620990.
PMID: 33816521
PMC: 8012486.
DOI: 10.3389/fmed.2021.620990.
Angiotensin-(1-7)-A Potential Remedy for AKI: Insights Derived from the COVID-19 Pandemic.
Heyman S, Walther T, Abassi Z
J Clin Med. 2021; 10(6).
PMID: 33805760
PMC: 8001321.
DOI: 10.3390/jcm10061200.
Renal Manifestations of Covid-19: Physiology and Pathophysiology.
Armaly Z, Kinaneh S, Skorecki K
J Clin Med. 2021; 10(6).
PMID: 33804075
PMC: 8000200.
DOI: 10.3390/jcm10061216.